Supercharge Your Innovation With Domain-Expert AI Agents!

Compound ablation mixture and application in preparing medicine for treating tumor

The technology of a mixture and a compound recipe is applied in the application field of preparing a drug for treating tumors, and can solve the problems of irritating odor, easy damage to surrounding normal tissues, and difficulty in obtaining the best curative effect, and achieve the effect of reducing toxic and side effects.

Inactive Publication Date: 2004-01-07
冯威健
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the curative effect of glacial acetic acid is three times that of ethanol, the boundary is not clear, and the coagulation necrosis area cannot form a sphere, which is difficult to obtain the best curative effect, and it is easy to damage the surrounding normal tissues, especially when it has a serious pungent smell during use, so it has not been widely used. Clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Under sterile conditions, put 10ml (18wt%) of analytically pure hydrochloric acid, 2ml (10wt%) of Uveshin, and 8ml (40wt%) of lidocaine into a medicine bottle for later use.

Embodiment 2

[0034] Under sterile conditions, put 10ml (18wt%) of analytically pure hydrochloric acid, 2ml (10wt%) of Aesopin, and 8ml (40wt%) of lidocaine into a medicine bottle for later use.

Embodiment 3

[0036] Under sterile conditions, put 10ml (18wt%) of analytically pure hydrochloric acid, 2ml (10wt%) of Omnipaque, and 8ml (40wt%) of lidocaine into a medicine bottle for later use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a compound ablation mixture and its application for preparing mecicine for curing tumor. It is characterized by that on the basis of chemical ablation agent the non-ionic type contrast medium, local anesthetic and chemical ablation agent are mixed to obtain the invented compound ablation mixture with the function of making tumor tissue be coagulated ana necrotic, so that it can be used for curing variou s tumors and cancers.

Description

technical field [0001] The invention relates to the use of a compound ablation agent, in particular to a compound ablation agent composed of a chemical ablation agent for malignant tumors, a non-ionic contrast agent and a local anesthetic, and its application in preparing a drug for treating tumors. Background technique [0002] Tumors, especially malignant tumors, are mainly surgically resected. In the past two decades, some methods of non-surgical local treatment of malignant tumors have been developed, such as chemical methods and physical methods, the purpose of which is to cause tumor necrosis and minimize damage to normal tissues. Among them, physical methods such as X-knife use radiation to position and irradiate tumors; ultrasonic focusing knife uses ultrasonic heating to destroy tumors; microwave and radio frequency use heat to coagulate tumors; These methods can coagulate and kill tumor tissue more accurately after guided positioning, but the disadvantages are tha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/04A61K31/045A61K31/185A61K49/00A61K49/04A61P35/00
CPCA61K31/045A61K49/0438A61K31/185A61K31/04A61K49/0447A61P35/00A61K2300/00
Inventor 冯威健
Owner 冯威健
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More